ADAR and neoplasm: Basically, the study showed that LINC00944 is responsive to ADAR1 up- and downregulation in breast cancer cells; LINC00944 expression has a strong relationship with immune signaling; and LINC00944 expression is correlated with the age at diagnosis, tumor size, and estrogen and progesterone receptor expression [95].